KRT73: A Potential Drug Target and Biomarker for Various Diseases

Target Name: KRT73

NCBI ID: G319101

KRT73

KRT73: A Potential Drug Target and Biomarker for Various Diseases

KRT73 (keratin 6 irs3) is a protein that is expressed in human hair follicles and is composed of 186 amino acids. It is a key component of the hair interphase, which is the portion of the hair that is growing. KRT73 is also known as IRAS4A, and it has been identified as a potential drug target and biomarker for various diseases, including cancer.

The hair interphase is the portion of the hair that is responsible for growth and development. This phase is characterized by the production of new hair fibers, which are composed of a protein called keratin. Keratin is a protein that is derived from the skin, and it is responsible for the strength and resilience of the hair. The production of keratin is regulated by a variety of factors, including KRT73.

KRT73 is a protein that is expressed in the hair follicles, and it plays a key role in the production and distribution of keratin in the hair interphase. It is made up of 186 amino acids, and it has a calculated molecular weight of 21.9 kDa. KRT73 is found in the extracellular matrix (ECM) of the hair follicles, and it is involved in the formation of the interphase of the hair.

KRT73 has been identified as a potential drug target and biomarker for various diseases, including cancer. For example, studies have shown that high levels of KRT73 are associated with an increased risk of cancer, particularly breast cancer. Additionally, KRT73 has been shown to be involved in the development of skin cancer, and it has been identified as a potential therapeutic target for these diseases.

In addition to its potential as a drug target and biomarker, KRT73 is also of interest as a potential therapeutic target for other conditions. For example, KRT73 has been shown to be involved in the development of age-related diseases, such as Alzheimer's disease and Parkinson's disease. Additionally, KRT73 has been shown to be involved in the development of autoimmune diseases, such as rheumatoid arthritis and multiple sclerosis.

KRT73 is also of interest as a potential therapeutic target for diseases that are characterized by inflammation. For example, KRT73 has been shown to be involved in the development of inflammatory diseases, such as cancer and autoimmune diseases. Additionally, KRT73 has been shown to be involved in the regulation of inflammation, and it has been identified as a potential therapeutic target for diseases characterized by inflammation.

In conclusion, KRT73 is a protein that is expressed in the hair follicles and is involved in the production and distribution of keratin in the hair interphase. It has been identified as a potential drug target and biomarker for various diseases, including cancer, and it is of interest as a potential therapeutic target for other conditions. Further research is needed to fully understand the role of KRT73 in these diseases and to develop effective treatments.

Protein Name: Keratin 73

Functions: Has a role in hair formation. Specific component of keratin intermediate filaments in the inner root sheath (IRS) of the hair follicle (Probable)

The "KRT73 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about KRT73 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets